Active Shortage

ACT BORTEZOMIB

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ACT BORTEZOMIB in Canada?

Yes. ACT BORTEZOMIB 3.5MG has an active shortage reported to Health Canada (last updated January 23, 2025).

Why is ACT BORTEZOMIB not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ACT BORTEZOMIB be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file4 products · 3 same form & route

Affected strength3.5MG

Report last updated2025-01-23

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

BORTEZOMIB

APOTEX INC

3.5MG · DIN 02456176

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-BORTEZOMIB

PHARMASCIENCE INC

3.5MG · DIN 02466708

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

VELCADE

JANSSEN INC

3.5MG · DIN 02262452

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

BORTEZOMIB INJECTION

DR REDDY'S LABORATORIES LTD

2.5MG · DIN 02550075

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02438399

Strength

3.5MG

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

BORTEZOMIB

Tier

Unrated

Last Updated

2025-01-23

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163

750MG · DIN 02247341